These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35821800)

  • 1. Roadmap for Sex-Responsive Influenza and COVID-19 Vaccine Research in Older Adults.
    Shapiro JR; Morgan R; Leng SX; Klein SL
    Front Aging; 2022; 3():836642. PubMed ID: 35821800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Frailty, Age, and Biological Sex With Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine-Induced Immunity in Older Adults.
    Shapiro JR; Sitaras I; Park HS; Aytenfisu TY; Caputo C; Li M; Lee J; Johnston TS; Li H; Wouters C; Hauk P; Jacobsen H; Li Y; Abrams E; Yoon S; Kocot AJ; Yang T; Huang Y; Cramer SM; Betenbaugh MJ; Debes AK; Morgan R; Milstone AM; Karaba AH; Pekosz A; Leng SX; Klein SL
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S61-S71. PubMed ID: 35607747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Technical guidelines for seasonal influenza vaccination in China (2023-2024)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Oct; 44(10):1507-1530. PubMed ID: 37875437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1515-1544. PubMed ID: 36456484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond.
    Weinberger B
    Immun Ageing; 2021 Oct; 18(1):38. PubMed ID: 34627326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a difference in the immune response, efficacy, effectiveness and safety of seasonal influenza vaccine in males and females? - A systematic review.
    Tadount F; Doyon-Plourde P; Rafferty E; MacDonald S; Sadarangani M; Quach C
    Vaccine; 2020 Jan; 38(3):444-459. PubMed ID: 31711676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines.
    McElhaney JE; Kuchel GA; Zhou X; Swain SL; Haynes L
    Front Immunol; 2016; 7():41. PubMed ID: 26941738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study.
    Izikson R; Brune D; Bolduc JS; Bourron P; Fournier M; Moore TM; Pandey A; Perez L; Sater N; Shrestha A; Wague S; Samson SI
    Lancet Respir Med; 2022 Apr; 10(4):392-402. PubMed ID: 35114141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty.
    DiazGranados CA; Dunning AJ; Robertson CA; Talbot HK; Landolfi V; Greenberg DP
    Vaccine; 2015 Aug; 33(36):4565-71. PubMed ID: 26187260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults.
    Harris DA; Hayes KN; Zullo AR; Mor V; Chachlani P; Deng Y; McCarthy EP; Djibo DA; McMahill-Walraven CN; Gravenstein S
    JAMA Netw Open; 2023 Aug; 6(8):e2326852. PubMed ID: 37531110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare workers' perceptions and experiences of communicating with people over 50 years of age about vaccination: a qualitative evidence synthesis.
    Glenton C; Carlsen B; Lewin S; Wennekes MD; Winje BA; Eilers R;
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013706. PubMed ID: 34282603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
    Lazarus R; Baos S; Cappel-Porter H; Carson-Stevens A; Clout M; Culliford L; Emmett SR; Garstang J; Gbadamoshi L; Hallis B; Harris RA; Hutton D; Jacobsen N; Joyce K; Kaminski R; Libri V; Middleditch A; McCullagh L; Moran E; Phillipson A; Price E; Ryan J; Thirard R; Todd R; Snape MD; Tucker D; Williams RL; Nguyen-Van-Tam JS; Finn A; Rogers CA;
    Lancet; 2021 Dec; 398(10318):2277-2287. PubMed ID: 34774197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.
    Bowman KA; Stein D; Shin S; Ferbas KG; Tobin NH; Mann C; Fischinger S; Ollmann Saphire E; Lauffenburger D; Rimoin AW; Aldrovandi G; Alter G
    mBio; 2022 Oct; 13(5):e0164722. PubMed ID: 36000735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for older adults.
    Cunningham AL; McIntyre P; Subbarao K; Booy R; Levin MJ
    BMJ; 2021 Feb; 372():n188. PubMed ID: 33619170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exclusive and dual influenza and COVID-19 vaccination among U.S. adults and adolescents in 2021.
    Nguyen KH; Zhao R; Chen S; Bednarczyk RA
    Ann Med; 2023 Dec; 55(1):2196436. PubMed ID: 37052255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies.
    Janssen C; Mosnier A; Gavazzi G; Combadière B; Crépey P; Gaillat J; Launay O; Botelho-Nevers E
    Hum Vaccin Immunother; 2022 Nov; 18(6):2131166. PubMed ID: 36256633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-based biology and the rational design of influenza vaccination strategies.
    Klein SL; Pekosz A
    J Infect Dis; 2014 Jul; 209 Suppl 3(Suppl 3):S114-9. PubMed ID: 24966191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.